C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
12/2002
12/10/2002	US6492424 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders
12/10/2002	US6492423 Hepatitis c and b viricides
12/10/2002	US6492418 Administering benzamide-disulfide derivative for therapy and prophylaxis of allergic disease of the eye, nose, skin, ear, gastrointestinal tract or lung and manifestations of systemic mastocytosis
12/10/2002	US6492396 Substituted thioacetamides
12/10/2002	US6492393 Compounds useful as anti-inflammatory agents
12/10/2002	US6492375 Administering a piperidine compound
12/10/2002	US6492372 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
12/10/2002	US6492370 Urea derivatives and pharmaceutical compositions thereof
12/10/2002	US6492369 Drug abruse
12/10/2002	US6492368 Benzamidine derivatives as factor XA inhibitors
12/10/2002	US6492367 Sulfamato hydroxamic acid metalloprotease inhibitor
12/10/2002	US6492365 Microsomal triglyceride transfer protein
12/10/2002	US6492363 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives
12/10/2002	US6492362 Compounds and compositions as cathepsin S inhibitors
12/10/2002	US6492355 Adamantane derivatives
12/10/2002	US6492351 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
12/10/2002	CA2230445C Fibrinogen receptor antagonists and medicinal preparations containing the same as the active ingredient
12/09/2002	WO2002004403A1 Biphenylcarboxylic acid amides, production thereof and use thereof as medicaments
12/09/2002	CA2412116A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments
12/05/2002	WO2002097050A2 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions
12/05/2002	WO2002096897A1 PHOSPHINYLMETHYL AND PHOSPHORYLMETHYL SUCCINIC AND GLUTARIC ACID ANALOGS AS β-SECRETASE INHIBITORS
12/05/2002	WO2002096884A2 Substituted benzoylketones as herbicidal agents for use as plant treatment agent
12/05/2002	WO2002096876A1 Carbamate and oxamide compounds as inhibitors of cytokine production
12/05/2002	WO2002096874A2 Method for producing biperiden iv
12/05/2002	WO2002096869A2 Piperazine mono(dithio)carbamate ester compounds and analogs thereof
12/05/2002	WO2002096864A1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments
12/05/2002	WO2002096858A1 Cinnamide derivatives as kcnq potassium channel modulators
12/05/2002	WO2002096855A2 Anticholinergic compounds and methods of use
12/05/2002	WO2002096854A1 N-benzyl-m-phenylenediamine derivatives and dyes containing said compounds
12/05/2002	US20020183518 Use for treatment of human and animal disorders, for purification of proteins or glycoproteins, and in diagnosis
12/05/2002	US20020183517 Reacting dihydric alcohol characterized by four to six carbons, preferably 1,5-pentanediol, with excess ammonia in presence of ZSM-5 catalyst modified with nickel, copper or cobalt
12/05/2002	US20020183512 Compounds for use in treatment of cancer
12/05/2002	US20020183397 Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
12/05/2002	US20020183342 For use as insecticides against a variety of insects, including larvae, such as tobacco budworm
12/05/2002	US20020183334 For therapy of sleepiness, promotion of wakefulness, treatment of Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, treatment of attention deficit hyperactivity disorder
12/05/2002	US20020183316 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
12/05/2002	DE10126929A1 Production of compounds with perfluoroalkanesulfonic acid residues, used e.g. in electrolytes and batteries, involves reacting perfluoroalkanesulfonic anhydride with dialkyl carbonate in presence of perfluoroalkanesulfonic acid
12/05/2002	DE10125567A1 New N-aroyl-N'-(carbamoyl-phenyl)-urea derivatives, are glycogen phosphorylase a inhibiting hypoglycemic agents, especially useful for treating type II diabetes
12/05/2002	CA2448894A1 Cinnamide derivatives as kcnq potassium channel modulators
12/05/2002	CA2448626A1 Carbamate and oxamide compounds as inhibitors of cytokine production
12/05/2002	CA2448023A1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments
12/05/2002	CA2443346A1 Anticholinergic compounds and methods of use
12/05/2002	CA2442212A1 N-benzyl-m-phenylenediamine derivatives and dyes containing said compounds
12/05/2002	CA2411082A1 Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
12/04/2002	EP1261595A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
12/04/2002	EP1261594A1 5,10-dihydroacridines as calcium channel blockers
12/04/2002	EP1261590A1 Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
12/04/2002	EP1261329A2 Il-8 receptor antagonists
12/04/2002	EP1261321A2 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof
12/04/2002	CN1382440A Method and medicine case for treating depression or preventing degeneration of cognitive function
12/03/2002	US6489480 Coordination polymerization catalyst for alpha-olefins
12/03/2002	US6489374 Organonitrogen compounds that yield amines, imines or amidines when exposed to visible or ultraviolet radiation; polymerization catalysts used in one-pot systems having storage stability
12/03/2002	US6489327 Tryptase inhibitors
11/2002
11/28/2002	WO2002095393A2 Drug evolution: drug design at hot spots
11/28/2002	WO2002094801A1 Method for producing biperiden i
11/28/2002	WO2002094800A1 Method for the production of biperidin
11/28/2002	WO2002094799A2 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/28/2002	WO2002094794A1 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
11/28/2002	WO2002094781A1 Method for the production of biperiden ii
11/28/2002	WO2002094208A1 Novel couplers for use in oxidative hair dyeing
11/28/2002	WO2002062777A3 Amino ceramide-like compounds and therapeutic methods of use
11/28/2002	US20020177598 Inhibit activity of chemokines, macrophage inflammatory protein-1 (MIP-1 alpha) and RANTES; 1-((4-chlorophenoxy)methyl)-carbonyl-2-methyl-4-(4-fluorobenzyl)piperazine for example
11/28/2002	US20020177594 Inhibitors of histone deacetylase
11/28/2002	DE10125451A1 New N-benzyl-m-phenylenediamine derivatives and physiologically-compatible, water-soluble salts are used in oxidative colorant for keratin fibers, especially human hair
11/28/2002	DE10125432A1 New benzoyl-substituted aliphatic ketones or aldehydes, useful as herbicides or fungicides, especially as pre- and post-emergence selective herbicides against a broad spectrum of weeds
11/28/2002	DE10124867A1 New substituted (hetero)aryl-alkenes or -alkynes, used as thrombin inhibitors, serine protease inhibitors, antithrombotic agents and intermediates
11/28/2002	CA2448080A1 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/28/2002	CA2434036A1 Novel couplers for use in oxidative hair dyeing
11/27/2002	EP1260504A1 Process for the preparation of antihistaminic 4-diphenylmethyl piperidine derivatives
11/27/2002	EP1259493A2 Substituted piperazine compounds
11/27/2002	EP1259492A1 Substituted piperazine derivatives as mtp inhibitors
11/27/2002	EP1259484A1 Carboxamides useful as inhibitors of microsomal triglyceride transfer protein and of apolipoprotein b secretion
11/27/2002	EP1259478A1 Covalent derivatives of alkanolamides of monocarboxylic and dicarboxylic acids functionally active on the cb2 cannabinoid receptor
11/27/2002	EP1259475A1 Transition metal-catalyzed process for addition of amines to carbon-carbon double bonds
11/27/2002	EP1259470A2 A group of anti-cancer compounds with specific structure and their production method
11/27/2002	EP1114024B1 Urokinase inhibitors
11/27/2002	EP1109557B1 Use of cetirizine for preventing the onset of asthma
11/27/2002	EP1000048B1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
11/27/2002	CN1382135A Amine and amide derivatives as ligands for neuropeptide YY5 receptor usefu in treatment of obesity and other disorders
11/27/2002	CN1381454A Method for preparing oxazolidone amine
11/27/2002	CN1381449A Aralkylone pipeazine derivative and its application
11/27/2002	CN1381448A Aralkylformylalkyl piperazine derivative and its application as brain nerve protector
11/26/2002	US6486324 Forming libraries of bactericides; immobilization; side effect reduction
11/26/2002	US6486178 Indane derivatives
11/26/2002	US6486165 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
11/26/2002	CA2231364C Novel n-aminoalkylfluorenecarboxamides; a new class of dopamine receptor subtype specific ligands
11/24/2002	CA2354921A1 Drug evolution: drug design at hot spots
11/22/2002	WO2003101942A1 Amidine substituted aryl and heteroaryl derivatives with an antithrombotic and factor xa inhibiting action
11/22/2002	CA2445571A1 Substituted aryl and heteroaryl derivatives, the preparation thereof and the use thereof as pharmaceutical compositions
11/21/2002	WO2002092585A1 Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
11/21/2002	WO2002092574A1 Substituted benzoylcyclohexenones and their use as herbicidal agents
11/21/2002	WO2002092068A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient
11/21/2002	WO2002091993A2 Estrogen receptor modulators
11/21/2002	WO2002072084A3 Glycyrrhetinic acid derivatives, progesterone and progesterone derivatives and their use for the manufacture of a medicament to inhibit 11beta-hydroxysteroid dehydrogenase activity
11/21/2002	US20020173665 Use treating pain, urinary incontinence and bladder overactivity
11/21/2002	US20020173664 An 3-acyl-4-substituted-oxazolidin-2,5-dione that readily reacts with nucleophilic reagents such as free amino acids; use in peptide synthesis for example
11/21/2002	US20020173645 Acylating a 2-aryl-6-alkoxy-benzo(b)thiophene with a p-(tertiaryaminoethoxy)benzoic acid hydrohalide salt or the corresponding benzoyl halide in presence of a boron trihalide
11/21/2002	US20020173508 Enzyme inhibitors; antiinflammatory agents, antiarthritic agents
11/21/2002	US20020173494 Ammonium salts of inositol hexaphosphate, and uses thereof
11/21/2002	US20020173488 Boronic Ester and acid compounds, synthesis and uses

1 ... 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 ... 341